Back to search

Article

NN-800s: Brain-penetrant trimeric nanobodies enable potent TNFα inhibition via TfR1-mediated transcytosis

2026-04-30

Abstract excerpt

Tumor necrosis factor alpha (TNFα) is a central mediator of neuroinflammation and synaptic dysfunction in multiple central nervous system (CNS) disorders, including Alzheimer’s disease. Although clinically approved TNFα inhibitors are highly effective in peripheral inflammatory diseases, their therapeutic application in CNS disorders is severely limited by poor blood–brain barrier (BBB) penetration. Here, we repor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
96c3c3de-e68e-5bf3-867b-f40968f14c3b
DOI
10.64898/2026.04.28.721316
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NN-800s: Brain-penetrant trimeric nanobodies enable potent TNFα inhibition via TfR1-mediated transcytosisDOI 10.64898/2026.04.28.721316
Select a neighboring publication to make it the new centre.